News
Shardul Nautiyal, Mumbai Monday, August 18, 2025, 08:00 Hrs [IST] ...
Gireesh Babu, New Delhi Monday, August 18, 2025, 08:00 Hrs [IST] The Jan Aushadhi Kendras (JAKs), the low cost generic me ...
Pharmacy admissions in limbo as PCI approvals delay counselling: Peethaambaran Kunnathoor, Chennai Monday, August 18, 2025, 08:00 Hrs [IST] The pharmacy colleges across the countr ...
India needs stronger environmental regulations to thwart spread of antibiotic resistance: Saransh Chaudhary: Nandita Vijayasimha, Bengaluru Monday, August 18, 2025, 08:00 Hrs [IST ...
CMHA notifies classifications and categories of mental health establishments: Gireesh Babu, New Delhi Monday, August 18, 2025, 08:00 Hrs [IST] The Central Mental Health Authority ...
Pilatus Biosciences inks clinical trial collaboration with Roche to evaluate PLT012 in first-in-human study in hepatocellular carcinoma: Epalinges, Switzerland Saturday, August 16 ...
Vyome Therapeutics receives Nasdaq Stock Market approval to merge with ReShape Lifesciences: Cambridge, Massachusetts Saturday, August 16, 2025, 17:00 Hrs [IST] Vyome Therapeutics ...
Study reveals how small changes in walking technique may help treat knee osteoarthritis: New York Saturday, August 16, 2025, 16:00 Hrs [IST] Gait analysis and pain measures show t ...
AleraCare, PURE Healthcare enter into merger agreement to enhance availability of infusion services: Phoenix Saturday, August 16, 2025, 15:00 Hrs [IST] AleraCare, a leading provid ...
Leads Biolabs completes patient enrollment in pivotal trial of Opamtistomig monotherapy for extrapulmonary neuroendocrine carcinoma: Nanjing, China Saturday, August 16, 2025, 14:0 ...
Basilea Pharma enters licensing pact with Venatorx Pharma to acquire rights to ceftibuten-ledaborbactam etzadroxil, a clinical phase 3-ready oral BL/BLI combo to treat cUTI Allschwil, Switzerland ...
ScaleReady awards multiple G-Rex grants to leading investigators at the USC and CHLA: St. Paul, Minnesota Saturday, August 16, 2025, 12:00 Hrs [IST] ScaleReady in collaboration wi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results